Focalin XR(TM) Approved for Treatment of ADHD in Adults, Adolescents and Children

Main Category: ADHD
Article Date: 13 Jun 2005 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:3 and a half stars

3.41 (22 votes)

Healthcare Prof:3 and a half stars

3.2 (5 votes)

Article Opinions: 257 posts

The FDA has just approved focalin XR(TM), a new long-acting medication for adults, adolescents and children who struggle with attention- deficit/hyperactivity disorder also known as ADHD. In adults, adolescents and Children, the core symptoms of adhd are inattention, impulsivity and Hyperactivity. Approximately 50 to 70 percent of children with adhd will Continue to experience symptoms into adulthood.

Doctor Lenard Adler, Associate Professor of Clinical Psychiatry and Neurology, NYU School of Medicine:

"Ideally when we're looking for effects of ADHD medication, we're looking for a medicine that will start quickly, have effects throughout the day and this is what Focalin XR has been shown to do. When an adult gets their ADHD treated, a variety of things may improve in their life: their work performance may improve, the quality of their relationships may improve, and their ability to get things done may also get better."

For more information about ADHD treatment with Focalin XR, visit http://www.FocalinXR.com.

NOTE TO PRODUCERS: Like most drugs approved for the treatment of ADHD, Focalin XR is contraindicated in patients known to be hypersensitive to the drug or to methylphenidate, in patients with glaucoma, and in patients with motor tics or with a family history or diagnosis of Tourette's syndrome. It is also contraindicated during treatment with monoamine oxidase inhibitors and also within a minimum of 14 days following discontinuation of a monoamine oxidase inhibitor (hypertensive crises may result). In addition, like most drugs approved for the treatment of ADHD, Focalin XR is a schedule II drug and should be given cautiously to patients with a history of drug dependence or alcoholism.

Novartis Pharmaceuticals
http://www.multivu.com
http://www.FocalinXR.com

View drug information on Focalin.


Article adapted by Medical News Today from original press release.
Visit our adhd section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Nora Beattie. "Focalin XR(TM) Approved for Treatment of ADHD in Adults, Adolescents and Children." Medical News Today. MediLexicon, Intl., 13 Jun. 2005. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/26022.php>

APA
Nora Beattie. (2005, June 13). "Focalin XR(TM) Approved for Treatment of ADHD in Adults, Adolescents and Children." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/26022.php.

Please note: If no author information is provided, the source is cited instead.


ADHD

What is ADHD?

Health experts say that ADHD (attention deficit hyperactivity disorder) is the most common behavioral disorder that starts during childhood. However, it does not only affect children - people of all ages can suffer from ADHD. Read more...

Most Popular Articles



Follow Our ADHD News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our ADHD Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »